Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Femi O Babatunde"'
Autor:
Sylvanus Okogbenin, Cyril Erameh, Joseph Okoeguale, Osahogie Edeawe, Esele Ekuaze, Kelly Iraoyah, John Agho, Mirjam Groger, Benno Kreuels, Lisa Oestereich, Femi O. Babatunde, Peter Akhideno, Stephan Günther, Michael Ramharter, Till Omansen
Publikováno v:
Emerging Infectious Diseases, Vol 28, Iss 10, Pp 2060-2063 (2022)
Lassa fever is a viral hemorrhagic fever treated with supportive care and the broad-spectrum antiviral drug ribavirin. The pathophysiology, especially the role of hyperinflammation, of this disease is unknown. We report successful remission of compli
Externí odkaz:
https://doaj.org/article/a804aa399add43bdb7e283df43aac174
Autor:
Mirjam Groger, Peter Akhideno, Christine J Kleist, Femi O Babatunde, Osahogie Edeawe, Julia Hinzmann, ThankGod Akhigbe, Joy Nwatuzor, Gloria Eifediyi, Jonas Müller, Mette Hinrichs, Meike Pahlmann, Francisca Naana Sarpong, Christine Wagner, Anke Thielebein, Louis Aihonwalan, Till Koch, Maria Riedner, Ephraim Ogbaini-Emovon, Sylvanus Okogbenin, Stephan Günther, Sebastian G Wicha, Michael Ramharter, Lisa Oestereich, Sophie Duraffour, Cyril Erameh
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
Background Lassa fever is endemic in large parts of West Africa. The recommended antiviral treatment is ribavirin. Two treatment regimens are currently endorsed in Nigeria: the “McCormick regimen” based on a study published in 1986 and the “Irr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63311f00ee477b1ef505ba8e732666ef
https://pubmed.ncbi.nlm.nih.gov/35881530
https://pubmed.ncbi.nlm.nih.gov/35881530